Researchers at the Southwest Foundation for Biomedical Research in San Antonio found that an experimental antiviral drug called SPC3649 suppresses hepatitis C in chimpanzees. UTMB microbiologist Stanley M. Lemon, who was not involved in the research, said, “The thing that makes [the new drug] quite special compared to other direct-acting antiviral agents is that there does not seem to be any resistance developing.” A similar article appears in the online component of Science Magazine.